Mount Sinai Medical Center Urology Program Offers Most Advanced Treatments Available

MIAMI, Oct. 25, 2012 /PRNewswire/ -- Mount Sinai Medical Center in Miami Beach, FL, is proud to have Florida's only Ivy League urology affiliation, thanks to an innovative partnership with New York's prestigious Columbia University.

The Columbia University Division of Urology at Mount Sinai offers the most advanced minimally invasive treatment options available for prostate cancer, kidney and bladder cancers, as well as other urological disorders, including the unique urological needs of women.

Robotic and Minimally Invasive Options
Robotic surgery is a minimally invasive option for treating a number of urological diseases. Mount Sinai's surgeons are skilled in performing a catheterless, nerve-sparing robotic prostatectomy for the treatment of prostate cancer. Meanwhile, the development of minimally invasive robotic procedures has created new surgical options for kidney cancer treatment, bladder cancer and, cryotherapy, the freezing of tumors to kill cancerous cells. The center also provides specialized care for a variety of female urological problems, including vaginal prolapse, pelvic floor prolapse, urinary infection, incontinence and overactive bladder.

In 2012, Mount Sinai also initiated a fully accredited residency in urology, a distinction that underscores its commitment to the highest standards of medicine, academics and training.

About the Columbia University Division of Urology at Mount Sinai
Bringing together Columbia University's medical faculty with Mount Sinai's outstanding team of urologists, Mount Sinai's urology program is dedicated to giving you the care that patients need. Patients also have the comfort of knowing their doctors are part of a teaching program that is training the physicians of tomorrow and conducting lifesaving research for patients in Miami and all of South Florida.

Under the direction of Dr. Mitchell C. Benson, urologist-in-chief of Columbia University Medical Center, this Ivy League partnership combines top physicians with state-of-the-art surgical technology to diagnose and treat the full range of urologic conditions, including prostate cancer, benign prostate disease, bladder cancer, kidney stones and overactive bladder.

At the Mount Sinai Columbia University Division of Urology, patients have access to renowned physicians, groundbreaking clinical trials and cutting-edge procedures, such as robotic surgery and green light laser surgery, as well as advanced medical care emphasizing the prevention, early detection and treatment of prostate cancer. It also offers advanced care in female urology, one of the newest subspecialties in the field.

SOURCE Columbia University Division of Urology at Mount Sinai

Suggested Articles

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.

Bluebird has priced gene therapy Zynteglo at €1.575 million in Europe and promised a U.S. price in “reasonably close” range.

Generic pain drug maker Lannett is closing its plant in Wyoming and laying off the remaining 80 employees.